Cardiovascular Risk Prediction in Chronic Kidney Disease

Area of Science:

• Nephrology
• Cardiology
• Public Health

Background:

• Cardiovascular disease (CVD) is a significant complication in chronic kidney disease (CKD) patients.
• CVD risk is elevated even in early CKD stages, with CVD deaths comprising 50% of mortality in end-stage renal disease.
• Accurate CVD risk prediction is essential for identifying high-risk CKD individuals for intensive management.

Purpose of the Study:

• To review the applicability and performance of existing cardiovascular risk prediction tools in CKD patients.
• To highlight the need for novel CVD risk biomarkers and improved predictive models tailored for CKD populations.

Main Methods:

• Literature review of cardiovascular risk prediction tools.
• Analysis of model performance in CKD populations.
• Discussion of current challenges and future directions in CKD CVD risk assessment.

Main Results:

• General population CVD risk models demonstrate suboptimal performance in CKD patients.
• There is a growing interest in developing CKD-specific CVD risk biomarkers and predictive models.
• Continued research is needed to refine risk assessment strategies for CKD patients.

Conclusions:

• Cardiovascular risk prediction in CKD requires dedicated research and attention.
• Improved risk prediction models are vital for guiding clinical interventions and enhancing patient prognosis.
• The development of CKD-adapted risk assessment tools is a priority for clinical practice.